Novabridge Biosciences Stock Performance
| NBP Stock | 4.63 0.13 2.89% |
On a scale of 0 to 100, NovaBridge Biosciences holds a performance score of 8. The company secures a Beta (Market Risk) of 1.03, which conveys a somewhat significant risk relative to the market. NovaBridge Biosciences returns are very sensitive to returns on the market. As the market goes up or down, NovaBridge Biosciences is expected to follow. Please check NovaBridge Biosciences' downside variance, as well as the relationship between the accumulation distribution and market facilitation index , to make a quick decision on whether NovaBridge Biosciences' current price movements will revert.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in NovaBridge Biosciences are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Even with relatively uncertain fundamental drivers, NovaBridge Biosciences reported solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 2.89 | Five Day Return 16.33 | Year To Date Return 411.04 | Ten Year Return (62.96) | All Time Return (62.96) |
1 | NovaBridge Biosciences latest stock news and headlines - Yahoo Finance UK | 10/23/2025 |
2 | NovaBridge Biosciences adds CMO, SAB chair to advance VIS-101 toward 2026 - Stock Titan | 11/20/2025 |
3 | 12 Health Care Stocks Moving In Mondays After-Market Session | 11/24/2025 |
4 | NovaBridge Announces Presentation of Ragistomig Expanded Phase 1 Data at ESMO-IO | 12/04/2025 |
5 | Companies Like NovaBridge Biosciences Can Afford To Invest In Growth | 12/19/2025 |
| Begin Period Cash Flow | 302 M | |
| Total Cashflows From Investing Activities | -136 M |
NovaBridge | Build AI portfolio with NovaBridge Stock |
NovaBridge Biosciences Relative Risk vs. Return Landscape
If you would invest 342.00 in NovaBridge Biosciences on September 27, 2025 and sell it today you would earn a total of 121.00 from holding NovaBridge Biosciences or generate 35.38% return on investment over 90 days. NovaBridge Biosciences is generating 0.6331% of daily returns assuming volatility of 5.7664% on return distribution over 90 days investment horizon. In other words, 51% of stocks are less volatile than NovaBridge, and above 88% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
NovaBridge Biosciences Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for NovaBridge Biosciences' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as NovaBridge Biosciences, and traders can use it to determine the average amount a NovaBridge Biosciences' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1098
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | NBP | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average NovaBridge Biosciences is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NovaBridge Biosciences by adding it to a well-diversified portfolio.
NovaBridge Biosciences Fundamentals Growth
NovaBridge Stock prices reflect investors' perceptions of the future prospects and financial health of NovaBridge Biosciences, and NovaBridge Biosciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on NovaBridge Stock performance.
| EBITDA | (373.45 M) | ||||
| Net Income | (49.7 M) | ||||
| Total Debt | 3.88 M | ||||
| Cash Flow From Operations | (52.65 M) | ||||
| Total Asset | 212.68 M | ||||
| Retained Earnings | (1.29 B) | ||||
| Working Capital | 168.24 M | ||||
About NovaBridge Biosciences Performance
Assessing NovaBridge Biosciences' fundamental ratios provides investors with valuable insights into NovaBridge Biosciences' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the NovaBridge Biosciences is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | -1.2 K | -1.2 K | |
| Return On Tangible Assets | (0.76) | (0.80) | |
| Return On Capital Employed | (1.84) | (1.75) | |
| Return On Assets | (0.76) | (0.80) | |
| Return On Equity | (0.81) | (0.77) |
Things to note about NovaBridge Biosciences performance evaluation
Checking the ongoing alerts about NovaBridge Biosciences for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for NovaBridge Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| NovaBridge Biosciences is way too risky over 90 days horizon | |
| NovaBridge Biosciences appears to be risky and price may revert if volatility continues | |
| NovaBridge Biosciences has high likelihood to experience some financial distress in the next 2 years | |
| NovaBridge Biosciences was previously known as I Mab and was traded on NASDAQ Exchange under the symbol IMAB. | |
| Reported Net Loss for the year was (49.7 M) with profit before taxes, overhead, and interest of 0. | |
| NovaBridge Biosciences generates negative cash flow from operations | |
| Latest headline from finance.yahoo.com: Companies Like NovaBridge Biosciences Can Afford To Invest In Growth |
- Analyzing NovaBridge Biosciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether NovaBridge Biosciences' stock is overvalued or undervalued compared to its peers.
- Examining NovaBridge Biosciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating NovaBridge Biosciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of NovaBridge Biosciences' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of NovaBridge Biosciences' stock. These opinions can provide insight into NovaBridge Biosciences' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for NovaBridge Stock Analysis
When running NovaBridge Biosciences' price analysis, check to measure NovaBridge Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NovaBridge Biosciences is operating at the current time. Most of NovaBridge Biosciences' value examination focuses on studying past and present price action to predict the probability of NovaBridge Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NovaBridge Biosciences' price. Additionally, you may evaluate how the addition of NovaBridge Biosciences to your portfolios can decrease your overall portfolio volatility.